Assessing disease onset and progression in the SOD1 mouse model of ALS
暂无分享,去创建一个
Michel Kliot | Thomas Möller | T. Möller | M. Kliot | P. Weydt | Patrick Weydt | So Yon Hong | Soojie Hong
[1] N. Shibata. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase‐1 mutation , 2001, Neuropathology : official journal of the Japanese Society of Neuropathology.
[2] M. Gurney,et al. A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis , 1997, Acta Neuropathologica.
[3] D. Sanger,et al. Quantitative motor assessment in FALS mice: a longitudinal study , 1997, Neuroreport.
[4] J. Aitchison,et al. Decision-Making in Clinical Medicine , 1970, Journal of the Royal College of Physicians of London.
[5] Xiao-Hua Zhou,et al. Statistical Methods in Diagnostic Medicine , 2002 .
[6] J. Rothstein,et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS , 2002, Annals of neurology.
[7] M. Gurney,et al. Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis , 1996, Annals of neurology.
[8] J. Kong,et al. Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1 , 1998, The Journal of Neuroscience.
[9] J. Julien,et al. Pathways to motor neuron degeneration in transgenic mouse models. , 2002, Biochimie.
[10] Michael P. McDonald,et al. Mice lacking both subunits of lysosomal β–hexosaminidase display gangliosidosis and mucopolysaccharidosis , 1996, Nature Genetics.
[11] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[12] Ole A. Andreassen,et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis , 1999, Nature Medicine.